Carbon Biosciences Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$38M
- Investors
-
11
Carbon Biosciences General Information
Description
Developer of a gene therapy platform intended for the treatment of rare and genetic diseases. The company utilizes a proprietary library of novel parvovirus-based vectors designed to deliver larger genetic payloads with high tissue specificity and minimal immune response, enabling the biotechnology and healthcare markets to advance genetic medicines through improved viral delivery systems that support repeatable dosing and targeted pulmonary and cardiac applications.
Contact Information
Website
www.carbonbio.comCorporate Office
- 880 Winter Street
- Suite 2001
- Waltham, MA 02451
- United States
Corporate Office
- 880 Winter Street
- Suite 2001
- Waltham, MA 02451
- United States
Carbon Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 21-Jun-2022 | $38M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Stealth |
Carbon Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Carbon Biosciences Comparisons
Industry
Financing
Details
Carbon Biosciences Competitors (1)
One of Carbon Biosciences’s competitors is 4D Molecular Therapeutics, a Formerly VC-backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics | Formerly VC-backed | Emeryville, CA |
Carbon Biosciences Patents
Carbon Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026072721-A1 | Parvovirus compositions and methods for gene therapy | Pending | 25-Sep-2024 | ||
| WO-2026064736-A1 | Parvovirus compositions and related methods for gene therapy | Pending | 23-Sep-2024 | ||
| WO-2026064739-A1 | Parvovirus compositions and related methods for gene therapy | Pending | 23-Sep-2024 | ||
| EP-4683931-A1 | Parvovirus compositions and related methods for gene therapy | Pending | 23-Mar-2023 | ||
| US-20260265310-A1 | Parvovirus compositions and related methods for gene therapy | Pending | 23-Mar-2023 | C07K14/015 |
Carbon Biosciences Signals
Carbon Biosciences Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| AJU IB Investment | Venture Capital | Minority | ||
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| Camford Capital | Venture Capital | Minority | ||
| Cystic Fibrosis Foundation | Limited Partner | Minority |
Carbon Biosciences FAQs
-
When was Carbon Biosciences founded?
Carbon Biosciences was founded in 2021.
-
Where is Carbon Biosciences headquartered?
Carbon Biosciences is headquartered in Waltham, MA.
-
What is the size of Carbon Biosciences?
Carbon Biosciences has 16 total employees.
-
What industry is Carbon Biosciences in?
Carbon Biosciences’s primary industry is Drug Discovery.
-
Is Carbon Biosciences a private or public company?
Carbon Biosciences is a Private company.
-
What is the current valuation of Carbon Biosciences?
The current valuation of Carbon Biosciences is .
-
What is Carbon Biosciences’s current revenue?
The current revenue for Carbon Biosciences is .
-
How much funding has Carbon Biosciences raised over time?
Carbon Biosciences has raised $38M.
-
Who are Carbon Biosciences’s investors?
Agent Capital, AJU IB Investment, Astellas Venture Management, Camford Capital, and Cystic Fibrosis Foundation are 5 of 11 investors who have invested in Carbon Biosciences.
-
Who are Carbon Biosciences’s competitors?
4D Molecular Therapeutics is a competitor of Carbon Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process